Showing results (61-70 of 108) with videos related to
Sort By:
Pageof 11
Journal of Pain and Symptom Management|February 3, 2024
Management of Pain Medication in Patients With a History of Bariatric Surgery: A Systematic ReviewMatthieu Delaye, Arthur Geraud, Julia Delahousse, et al.Hormones & Cancer|July 17, 2014
The lack of antitumor effects of o,p'DDA excludes its role as an active metabolite of mitotane for adrenocortical carcinoma treatmentSégolène Hescot, Angelo Paci, Atmane Seck, et al.Placenta|June 23, 2026
Transplacental transfer of osimertinib and alectinib using an ex vivo human placental perfusion modelLaure Benoit, David Combarel, Marie-Noëlle Dieudonne, et al.Investigational New Drugs|November 14, 2016
Safety of raltegravir-based antiretroviral therapy in HIV-infected patients receiving multi-kinase inhibitorsPierre Loulergue, Mansouria Merad, Romain Coriat, et al.Endocrine-Related Cancer|May 23, 2013
Mitotane alters mitochondrial respiratory chain activity by inducing cytochrome c oxidase defect in human adrenocortical cellsSégolène Hescot, Abdelhamid Slama, Anne Lombès, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 2, 2016
Quantitation of isocitrate dehydrogenase (IDH)-induced D and L enantiomers of 2-hydroxyglutaric acid in biological fluids by a fully validated liquid tandem mass spectrometry method, suitable for clinical applicationsVianney Poinsignon, Lionel Mercier, Koïchi Nakabayashi, et al.Cardiovascular and Interventional Radiology|February 24, 2012
Irinotecan loaded in eluting beads: preclinical assessment in a rabbit VX2 liver tumor modelPramod P Rao, Florentina Pascale, Atman Seck, et al.Journal of Vascular and Interventional Radiology : JVIR|May 9, 2015
Safety and efficacy compared between irinotecan-loaded microspheres HepaSphere and DC bead in a model of VX2 liver metastases in the rabbitJulien Namur, Florentina Pascale, Noboru Maeda, et al.European Journal of Endocrinology|November 4, 2011
High-dose mitotane strategy in adrenocortical carcinoma: prospective analysis of plasma mitotane measurement during the first 3 months of follow-upSophie Mauclère-Denost, Sophie Leboulleux, Isabelle Borget, et al.The Journal of Clinical Endocrinology and Metabolism|August 10, 2022
Succinate: A Serum Biomarker of SDHB-Mutated Paragangliomas and PheochromocytomasConstance Lamy, Hubert Tissot, Matthieu Faron, et al.Pageof 11